Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 3, 2013, Pages 637-645

  Shah, Gul N ^a   Price, Tulin O ^a   Banks, William A ^b,c   Morofuji, Yoichi ^c   Kovac, Andrej ^c   Ercal, Nuran ^d   Sorenson, Christine M ^e   Shin, Eui S ^f   Sheibani, Nader ^f  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^e Pediatric Emergency Department   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE XII; CARBONATE DEHYDRATASE XIV; GLUCOSE; GLYCOSYLPHOSPHATIDYLINOSITOL; LIPOPOLYSACCHARIDE; MICROSOMAL AMINOPEPTIDASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MALE; MITOCHONDRION; MONOLAYER CULTURE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; APOPTOSIS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELLS, CULTURED; CEREBRUM; CHEMOKINES; CYTOKINES; ENDOTHELIAL CELLS; GLUCOSE; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NEUROGLIA; OXIDATIVE STRESS; PERICYTES; REACTIVE OXYGEN SPECIES;

EID: 84874442369     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.201400     Document Type: Article

References (40)

1. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, and Strittmatter K, et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468:557-561.
2. Balabanov R and Dore-Duffy P (1998) Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 53:637-644.
3. Bonkowski D, Katyshev V, Balabanov RD, Borisov A, and Dore-Duffy P (2011) The CNS microvascular pericyte: Pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 8:8.
4. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
5. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Almeida OP, and Davis TM (2008) Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 31:2103-2107.
6. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, and Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem 278:36027-36031.
7. Coisne C, Dehouck L, Faveeuw C, Delplace Y, Miller F, Landry C, Morissette C, Fenart L, Cecchelli R, and Tremblay P, et al. (2005) Mouse syngenic in vitro bloodbrain barrier model: A new tool to examine inflammatory events in cerebral endothelium. Lab Invest 85:734-746.
8. Dehouck MP, Jolliet-Riant P, Brée F, Fruchart JC, Cecchelli R, and Tillement JP (1992) Drug transfer across the blood-brain barrier: Correlation between in vitro and in vivo models. J Neurochem 58:1790-1797.
9. Dodgson SJ, Forster RE, 2nd, Storey BT, and Mela L (1980) Mitochondrial carbonic anhydrase. Proc Natl Acad Sci USA 77:5562-5566.
10. Dore-Duffy P, Mehedi A, Wang X, Bradley M, Trotter R, and Gow A (2011) Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent. Microvasc Res 82:18-27.
11. Dore-Duffy P (2008) Pericytes: Pluripotent cells of the blood brain barrier. Curr Pharm Des 14:1581-1593.
12. Dore-Duffy P, Katychev A, Wang X, and Van Buren E (2006) CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 26: 613-624.
13. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
14. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, and Brownlee M (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97: 12222-12226.
15. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, and Day WW (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial. Lancet 377: 1341-1352.
16. Giugliano D, Ceriello A, and Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267.
17. Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, and Niwa M (2004) Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept 123:77-83.
18. Hazen SA, Waheed A, Sly WS, LaNoue KF, and Lynch CJ (1997) Effect of carbonic anhydrase inhibition and acetoacetate on anaplerotic pyruvate carboxylase activity in cultured rat astrocytes. Dev Neurosci 19:162-171.
19. Hilvo M, Tolvanen M, Clark A, Shen B, Shah GN, Waheed A, Halmi P, Hänninen M, Hämäläinen JM, and Vihinen M, et al. (2005) Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 392:83-92.
20. Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, and Alexander JJ (2010) C5a alters blood-brain barrier integrity in experimental lupus. FASEB J 24:1682-1688.
21. Kis B, Kaiya H, Nishi R, Deli MA, Abrahám CS, Yanagita T, Isse T, Gotoh S, Kobayashi H, and Wada A, et al. (2002) Cerebral endothelial cells are a major source of adrenomedullin. J Neuroendocrinol 14:283-293.
22. Korshunov SS, Skulachev VP, and Starkov AA (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416:15-18.
23. Kovac A, Erickson MA, and Banks WA (2011) Brain microvascular pericytes are immunoactive in culture: Cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation 8:139.
24. Kowluru RA (2001) Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol 38:179-185.
25. Kowluru RA, Abbas SN, and Odenbach S (2004) Reversal of hyperglycemia and diabetic nephropathy: Effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabetes Complications 18:282-288.
26. Leniger T, Thöne J, and Wiemann M (2004) Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-/HCO3-exchange. Br J Pharmacol 142:831-842.
27. Lidington EA, Rao RM, Marelli-Berg FM, Jat PS, Haskard DO, and Mason JC (2002) Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol 282:C67-C74.
28. Liu Y, Fiskum G, and Schubert D (2002) Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80:780-787.
29. Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, Tanaka K, and Niwa M (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54:253-263.
30. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, and Hammes HP, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790.
31. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, and Supuran CT (2005) Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J Med Chem 48:7860-7866.
32. Parkkila AK, Scarim AL, Parkkila S, Waheed A, Corbett JA, and Sly WS (1998) Expression of carbonic anhydrase V in pancreatic beta cells suggests role for mitochondrial carbonic anhydrase in insulin secretion. J Biol Chem 273:24620-24623.
33. Price TO, Eranki V, Banks WA, Ercal N, and Shah GN (2012) Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology 153:362-372.
34. Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 82:510-529.
35. Scheef EA, Sorenson CM, and Sheibani N (2009) Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1. Am J Physiol Cell Physiol 296:C724-C734.
36. Shah GN, Hewett-Emmett D, Grubb JH, Migas MC, Fleming RE, Waheed A, and Sly WS (2000) Mitochondrial carbonic anhydrase CA VB: Differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles. Proc Natl Acad Sci USA 97:1677-1682.
37. Sly WS and Hu PY (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64:375-401.
38. Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, Kappelle LJ, and Mali WP; SMART Study Group (2008) Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 39:1600-1603.
39. Vander Heiden MG, Cantley LC, and Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033.
40. Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7:373-380.